Call for a new approach to the process of clinical trials and drug registration

British Medical Journal

Volumn 322, Issue 7291, 2001, Pages 920-923

  Jones, T C ^a,b  

^a Clinical Research Consultants   (Switzerland)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; DRUG INFORMATION; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MEDICAL ETHICS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW;

EID: 0035857977     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.322.7291.920     Document Type: Review

References (22)

1. Principles of therapeutics
2. Congress, the FDA, and new drug development: Before and after 1962
3. Recent developments in the design of phase II clinical trials
4. The Phase II/III transition. Toward the proof of efficacy in cancer clinical trials
5. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries
6. Drug trials hide conflicts for doctors
7. Conflict of interest
8. Ethical issues regarding randomized, placebo-controlled clinical trials and their publication in medical journals
9. Uneasy alliances - Clinical investigators and the pharmaceutical industry
10. Is academic medicine for sale?
11. Adjunctive therapy for septic shock: A review of experimental approaches
12. Design, management and costs of multinational trials
13. FDA regulation of the pharmaceutical industry
14. The pharmaceutical physician and the company medical department
15. Biopharmaceutical success rates and development times
16. Prescription-event and other forms of epidemiological monitoring of side-effects in the UK
17. The pharmaceutical industry - To whom is it accountable?
18. Incentives and penalties in health care: Getting the best from pharmaceutical development
19. Randomized, controlled trials, observational studies, and the hierarchy of research design
20. A comparison of observational studies and randomized, controlled trials